Chlamydia vaccine shows promise in early trial
A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).
Apr 12, 2024
0
60
A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).
Apr 12, 2024
0
60
Mailed at-home self-sampling for human papillomavirus (HPV) testing increases cervical cancer screening participation in underscreened populations by almost threefold, according to a study presented at the annual meeting ...
Apr 13, 2024
0
0
With the creation of safe and efficacious vaccines to target human papillomavirus in the first decade of this century, WHO has an ambitious target to lower cervical cancer incidence (mostly caused by HPV) and mortality by ...
Apr 29, 2024
0
0
Women who undergo regular Pap smears are no doubt familiar with the possibility of "precancerous" cells being detected.
Apr 12, 2024
0
0
Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide. While the immune system usually clears HPV infections, those that persist can ...
Apr 11, 2024
0
40
A new study from researchers at Wake Forest University School of Medicine shows that school entry requirements are linked to an increase in human papillomavirus (HPV) vaccinations.
Apr 29, 2024
0
0
Throat cancer is one of the fastest-growing cancers, and it is often linked to HPV. Oropharyngeal cancer, or throat cancer, is a type of head and neck cancer that can be divided into two subgroups: HPV-associated cancers ...
Apr 10, 2024
0
1
Every year in the U.S., human papillomavirus (HPV) causes about 37,000 new cases of cancer. These are cancers that could have been prevented with the HPV vaccine.
Apr 15, 2024
0
1
Some of the 10 women and teenage girls who recently came to a medical clinic in eastern Venezuela for free contraceptives fidgeted a bit when a community health worker taught them how to use an IUD, condoms and birth control ...
Apr 25, 2024
0
0
Part of the reproductive system, the cervix connects the vagina to the uterus, also known as the womb. By collecting cervical cells (called the Pap smear after the scientist who pioneered the screening test in the mid-1900s), ...
May 6, 2024
0
0
Alphapapillomavirus Betapapillomavirus Gammapapillomavirus Mupapillomavirus Nupapillomavirus
A human papillomavirus (HPV) is a papillomavirus that infects the epidermis and mucous membranes of humans. HPV can lead to cancers of the cervix, vulva, vagina, and anus in women. In men, it can lead to cancers of the anus and penis.
Approximately 130 HPV types have been identified. Some HPV types can cause warts (verrucae), but those types don't cause cancer. Other types can cause cancer, but those types don't cause warts. Other types have no symptoms and are harmless. Most people who become infected with HPV do not know they have it.
About 30-40 HPV types are typically transmitted through sexual contact and infect the anogenital region. Some sexually transmitted HPV types may cause genital warts. Persistent infection with "high-risk" HPV types—different from the ones that cause warts—may progress to precancerous lesions and invasive cancer. HPV infection is a cause of nearly all cases of cervical cancer. However most infections with these types do not cause disease.
Most HPV infections in young females are temporary and have little long-term significance. 70% of infections are gone in 1 year and 90% in 2 years.
A cervical Papanicolaou (Pap) test is used to detect abnormal cells which may develop into cancer. A cervical examination also detects warts and other abnormal growths which become visible as white patches of skin after they are washed with acetic acid. Abnormal and cancerous areas can be removed with a simple procedure, typically with a cauterizing loop.
Pap smears have reduced the incidence and fatalities of cervical cancer in the developed world, but even so there were 11,000 cases and 3,900 deaths in the U.S. in 2008. Cervical cancer has substantial mortality in resource-poor areas; worldwide, there are 490,000 cases and 270,000 deaths.
HPV vaccines, Gardasil and Cervarix, which prevent infection with the HPV types (16 and 18) that cause 70% of cervical cancer, may lead to further decreases.
This text uses material from Wikipedia, licensed under CC BY-SA